Afuco™ Anti-glycolipids ADCC Therapeutic Antibody (CEP-37250), ADCC Enhanced
Anti-glycolipids ADCC Enhanced Antibody (CEP-37250) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a humanized monoclonal antibody targeting glycolipids, with potential immunomodulating and antineoplastic activity. CEP-37250/KHK2804 targets and binds to a specific tumor antigen, thereby stimulating the immune system to exert an antibody-dependent cellular cytotoxicity (ADCC) against the tumor associated antigen (TAA)-expressing cancer cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-740CL |
| Pricing | Inquiry |
| Type | ADCC enhanced antibody |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |
| Host | Humanized |
| Target | glycolipids |